Share

January 20, 2015; 84 (3) Article

Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people

David B. Clifford, Florin Vaida, Yu-Ting Kao, Donald R. Franklin, Scott L. Letendre, Ann C. Collier, Christina M. Marra, Benjamin B. Gelman, Justin C. McArthur, Susan Morgello, David M. Simpson, Igor Grant, Robert K. Heaton, For the CHARTER Group
First published December 10, 2014, DOI: https://doi.org/10.1212/WNL.0000000000001156
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
314

Share

Article Information

vol. 84 no. 3 241-250
DOI: 
https://doi.org/10.1212/WNL.0000000000001156
PubMed: 
25503616
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received April 7, 2014
  • Accepted in final form August 18, 2014
  • First Published December 10, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. David B. Clifford, MD,
    2. Florin Vaida, PhD,
    3. Yu-Ting Kao, MS,
    4. Donald R. Franklin, BS,
    5. Scott L. Letendre, MD,
    6. Ann C. Collier, MD,
    7. Christina M. Marra, MD,
    8. Benjamin B. Gelman, MD, PhD,
    9. Justin C. McArthur, MBBS,
    10. Susan Morgello, MD,
    11. David M. Simpson, MD,
    12. Igor Grant, MD,
    13. Robert K. Heaton, PhD;
    14. For the CHARTER Group
  1. David B. Clifford, MD,
    2. Scientific Advisory Boards:

    1. Amgen - PML Adjudication Board 2012 - Biogen Idec/Quintiles - DSMB for progressive MS trial 2011 - BMS - PML Adjudication Committee 2012 - Genentech PML Advisory Board regarding PML 2007 - 2014 Genzyme DSMB for CARE MS Study 2008-2011 Pfizer DMC for MAdCAM study 2011 - Millennium - Chair PML IAC for clinical trials 2009 - 2014 Millennium - ADCETRIS trial adjudication committee member 2012 - Genentech - PML Adjudication Committee (Chair) Etrolizumab trials 2014 - Sanofi - DMSB for MS trial 2014 -

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Sun Pharmaceuticals - Speaker Honorarium - Symposium in Pune India (2013) Emory University - Speaker Honorarium for grand rounds University of Kansas - Speaker Honorarium for grand rounds

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Millennium Consulting regarding PML 2007-2014 Genzyme consultant 2009-2013 Biogen Idec scientific advisor regarding PML 2005-2014 IAS-USA speaker honorarium 2012 CMSC/ACTRIMS speaker honorarium 2012 ECTRIMS spearker honorarium 2012 Drinker, Biddle, Reath - Chair Scientific Advisory Committee of PML Consortium 2010 - Cytheris - PML trial design, FDA 2012 - 2013 Novartis - Case review consult for PML diagnosis - 2014

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Lilly (DIAN - TU) 2013 - Roche (DIAN - TU) 2013 -

    Research Support, Government Entities:

    1. NIH UO1 A169495 AIDS Clinical Trials Unit 2013-2020 NIH U10 NS077384 NeuroNEXT Trials Unit 2011- 2018 NIMH 22005 CHARTER Project (Washington U Site PI) 2007 - 2015 NIH R01 NR012907 (NINR,Ances - PI), Co-investigator, 2010- 2015 NIH R01 NR012907 (NINR, Ances - PI), Co-investigator, 2011-2016 DIAN TTU 12-243040 (Alzheimer Association, Bateman PI), Co-investigator, 2012-2016.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Arnold Todoro & Welch (legal consultation)2012 - Rainey, Kizer, Reviere, Bell (case review 2013 Silver and Deboskey PC (legal case review) 2013 Drinker Biddle and Reath LLC (PML Consortium Scientific Advisory Board) 2012 -

  2. Florin Vaida, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Research Methodology Section Editor for the Californian Journal of Health Promotion Editor, ISRN-AIDS Frontiers in Genetics, Research Editor

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Statistical Consultant for Washington University in St Louis.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH MH22005HIV, Investigator, 2006-2011 NIH MH083552, Investigator, 2008-2013 NIH MH62512, Investigator, 2007-2011 NIH AI074521, Investigator, 2007-2012 NIH MH085608, Investigator, 2009-2013 NIH MH58076, Investigator, 2008-2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Yu-Ting Kao, MS,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Eli Lilly and company, Sr. Statistician-computation, since 8/4/2014

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Donald R. Franklin, BS,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIMH N01 MH22005; HHSN271201000036C; HHSN271201000030C, Center Manager 2006-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Scott L. Letendre, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) ViiV Healthcare, 2013 (2) Abbvie, 2013

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Merck & Co., Inc., 2012

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) GlaxoSmithKline, Paid to the University of California (2) Merck & Co., Inc., Paid to the University of California (3) Abbvie, Paid to the University of California

    Research Support, Government Entities:

    1. (1) NIH, U01 MH083506, consultant, 2012 (2) NIH, R01 MH58076, co-investigator, 2012 (3) NIH, P50 DA26306, co-investigator, 2012, 2013 (4) NIH, R01 MH73433, co-investigator, 2012 (5) NIH, N01 MH22005, co-investigator, 2012, 2013 (6) NIH, P30 MH62512, co-investigator, 2012, 2013 (7) NIH, R01 MH78748, co-investigator, 2012 (8) NIH, R21 MH85610, principal investigator, 2012 (9) NIH, R01, MH92225, principal investigator, 2012, 2013 (10) NIH, K24, MH097673, principal investigator, 2013

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Ann C. Collier, MD,
    7. Scientific Advisory Boards:

    1. (1) Data and Safety Monitoring Board for Merck & Co.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Schering-Plough - past research contract (2) Merck & Co.- past research contract (3) Roche Molecular Systems - past research contract

    Research Support, Government Entities:

    1. (1) NIH/NIMH, N01 MH22005, Collier Co-PI on Subcontract, 3/12/03-8/31/15 (2) NIH/NIAID, UM1 AI 069481, Collier PI on Subcontract, 12/10/13 ? 11/30/2020 (3) NIH/NIAID, UM1 AI 069434, Collier, PI, 1/1/07-5/30/14 (4) NIH/NIAID, P01 AI 057005, Collier, Core PI, 10/01/03- 6/30/15 (5)NIH/NIMH, R01 NS082120, Collier Co-Investigator, 7/1/13-3/31/18 (6)NIH/NIAID, R01 AI090783, Collier, Co-Investigator, 6/1/10-5/31/14 (7)NIH/NIAID, UM1 AI068636, Co-Investigator, 6/1/13- 1/31/14 (8)NIH/NINDS, RC1NS068904, Collier, Co-Investigator, 9/22/09-8/31/12 (9)NIH/NIAID, AI069918, Co-Investigator of Subcontract, 4/1/06-6/30/16 (10)Social and Scientific Systems (pass through funds from NIH), CRB-SSS-5-11-000930/CRB-DCR01-5-09-00291, Collier, PI on contract, 2/2/11-3/31/13 (11)Social and Scientific Systems, pass through funds from NIH, BRS-ACURE-S-11-00046-001329, Collier, PI of contract, 6/1/10-5/31/12 Stock/Stock Options, Medical Equipment & Materials: (1) Abbott Laboratories, former stock owner, sold stock 8/23/12 (2) Bristol-Myers-Squibb, former stock owner, sold stock 8/23/12 (3) Johnson and Johnson, former stock owner, sold stock 8/23/12 (4) Pfizer, former stock owner, sold stock 8/23/12

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Christina M. Marra, MD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. I receive royalties from UpToDate for an article that I wrote on neurosyphilis. I receive royalties for a text entitled Infections of the Central Nervous System 4d ed, published by LWW in 2014.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) NIH, NS34235, PI, 1996-2014; NIH, NS082120, PI, 2013-14; NIH, MH22005, Co-investigator, 2003-2014; NIH, AI094126, Co-investigator, 2012-2014; NIH, AI069434, Site Neurologist, 2007-2013; NIH, AI094122, Co-investigator, 2011-2013; NIH, NS32228, Co-investigator, 1997-2011; NIH, AI068636, PI on subcontract, 2011-2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Benjamin B. Gelman, MD, PhD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) National Institute of Mental Health, U01MH083507, 2008- 2010. 2) National Institute of Mental Health, R01MH079886, 2006- 2010. 3) National Institute of Mental Health, N01MH022005, 2003- 2010.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Justin C. McArthur, MBBS,
    10. Scientific Advisory Boards:

    1. Relevare, scientific advisory board. 2006 - present. Stock options

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Murphy JC, Szczepanowski RP, Schneider W, Meyer RA, McArthur JC, Polydefkis M. Device for thermal stimulation of small neural fibers. World Intellectual Property Organization,International Publication Number WO 03/040672 A2, 15 May 2003. Murinson BB, McArthur JC. Medical Device for Treatment of Ulnar Neuropathy. UlnarGuard ? (JHU Ref: 4545) Nath A, Hoke A, McArthurJC. Immunophilin ligand treatment of antiretroviral toxic neuropathy (Provisional application number 60/466,650)

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen Idec 2009- (PI on clinical trial) Pfizer 2010 (PI on clinical trial)

    Research Support, Government Entities:

    1. NIH research funding 1986 - present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Foundation for Peripheral Neuropathy research grant 2008- present

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Susan Morgello, MD,
    11. Scientific Advisory Boards:

    1. Not-for-profit; Advisory Board member, Temple University Comprehensive NeuroAIDS Center (CNAC)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Neurovirology, editorial board, 2001 to present, no compensation received

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH: R24MH59724, U01MH083501, U24MH100931, PI, 1998-present R25MH080663, PI, 2007-present N01MH22005, Subsite PI, 2001-present R01DA037611, Subsite PI, 2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. David M. Simpson, MD,
    12. Scientific Advisory Boards:

    1. Scientific advisory board: Allergan,Merz, Astellas, Acorda

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speaker honoraria: Allergan

    Editorial Boards:

    1. AIDS Patient Care (2008-current)

    Patents:

    1. NONE

    Publishing Royalties:

    1. Neuropathic Pain: Mechanisms, Diagonosis and Management; Oxford; 2012

    Employment, Commercial Entity:

    1. Icahn School of Medicine at Mount Sinai

    Consultancies:

    1. Allergan, Acorda, Astellas

    Speakers' Bureaus:

    1. Allergan

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Allergan, Merz, Ipsen, US Worldmeds, Astellas, Viromed, CSL Behring

    Research Support, Government Entities:

    1. NINDS: R01-NS328-05-co-inv; R24 MH59724-co-inv;R01-NS- 41198-co-inv; NIMH-00-AI-0005-co-PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Peripheral Neuropathy Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Proctor and Gamble: 2012-2014

  12. Igor Grant, MD,
    13. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Abbott Pharmaceuticals speaker fee AbbVie speaker fee

    Editorial Boards:

    1. (1)Journal of the International Neuropsychological Society, Associate Editor, 2002-2004, (2) Journal of Neurovirology, Associate Editor, 2002-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Abbott Pharmaceuticals

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIDA, DA26306, PI, 2009-present, (2) NIMH, MH83506, PI, 2002-present, (3) NIMH, HHSN271201000036C, PI, 2010-present, (4) NIMH, HHSN271201000030C, PI, 2010-present, (5) NIMH, MH094159, Co-I, 2011-present (6) NIMH, MH62512, Co-I, 2011-present, (7) NIMH, MH78748, Co-I, 2007-2013, (8) NIMH, MH83552, Co-I, 2008-2013, (9) NIA, AG15301, PI, 2002-2012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Robert K. Heaton, PhD;
    14. Scientific Advisory Boards:

    1. (1) NINCDS, advisor, 2007-2010

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Journal of the International Neuropsychological Society, editorial board, 2000-present, (2) Journal of Clinical and Experimental Neuropsychology, editorial board, 2000-present, (3) The Clinical Neuropsychologist, editorial board, 2000-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Revised Comprehensive Norms for and Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults, Psychological Assessment Resources, Inc., 1991-present (2) Revised Comprehensive Norms for and Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults Scoring Program, Psychological Assessment Resources, Inc., 1994-present (3) Wisconsin Card Sorting Test Manual-Revised and Expanded, Psychological Assessment Resources, Inc., 1991-present

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1)NIH P30 MH62512, Co-Investigator, 2006-2010, (2)NIH P50 DA26306, Co-Investigator, 2009-2010, (3) NIH P01 DA12065, Co-Investigator, 2005-2010, (4) NIH R01 MH60720, Co-Investigator, 2006-2010, (5) NIH R01 MH73433, Principal Investigator, 2005-2010, (6) NIH N01 MH22005, Co-Investigator, 2002-2010, (7) NIH R01 MH58076, Co-Investigator, 2006-2010, (8) NIH R01 MH78748,Co-Investigator, 2007-2010, (9) NIH R01 MH78737, Co-Investigator, 2007-2010, (10) NIH U01 MH83506, Co-Investigator, 2008-2010, (11) NIH R01 MH83552,Co-Investigator, 2008-2010, (12) NIH R01 MH81861, Co-Investigator, 2008-2010, (13) NIH P30MH062512-11, Principal Investigator, 2011-2016.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. For the CHARTER Group
  1. From Washington University (D.B.C.), St. Louis, MO; University of California (F.V., Y.-T.K., D.R.F., S.L.L., I.G., R.K.H.), San Diego; University of Washington (A.C.C., C.M.M.), Seattle; University of Texas at Galveston (B.B.G.); Johns Hopkins University (J.C.M.), Baltimore, MD; and The Icahn School of Medicine at Mount Sinai (S.M., D.M.S.), New York, NY.
  1. Correspondence to Dr. Clifford: cliffordd{at}wustl.edu
View Full Text

Article usage

Article usage: December 2014 to September 2021

AbstractFullPdfSource
Dec 2014595029Highwire
Jan 201513281428Highwire
Feb 201529563Highwire
Mar 201516888Highwire
Apr 20157618Highwire
May 20156444Highwire
Jun 20157713Highwire
Jul 20158783Highwire
Aug 20156046Highwire
Sep 20155911Highwire
Oct 20153643Highwire
Nov 20154401Highwire
Dec 20154011Highwire
Jan 20165400Highwire
Jan 2016041pmc
Feb 20164101Highwire
Feb 2016085pmc
Mar 20163233Highwire
Mar 20160116pmc
Apr 20162800Highwire
Apr 20160119pmc
May 20165301Highwire
May 201601311pmc
Jun 20164512Highwire
Jun 2016095pmc
Jul 20164011Highwire
Jul 2016077pmc
Aug 20164211Highwire
Aug 201601310pmc
Sep 20163001Highwire
Sep 20160118pmc
Oct 20163811Highwire
Oct 2016054pmc
Nov 20164420Highwire
Nov 2016093pmc
Dec 20163700Highwire
Dec 20160135pmc
Jan 20173212Highwire
Jan 2017098pmc
Feb 20174000Highwire
Feb 20170107pmc
Mar 20172501Highwire
Mar 2017088pmc
Apr 20172300Highwire
Apr 2017475pmc
May 20173402Highwire
May 2017688pmc
Jun 20171300Highwire
Jun 20175813pmc
Jul 20171401Highwire
Jul 2017257pmc
Aug 20171901Highwire
Aug 201741011pmc
Sep 20171300Highwire
Sep 2017488pmc
Oct 20172200Highwire
Oct 2017288pmc
Nov 20171201Highwire
Nov 2017676pmc
Dec 20171502Highwire
Jan 20181901Highwire
Feb 20182100Highwire
Mar 20184211Highwire
Apr 20182200Highwire
Apr 2018144pmc
May 20183900Highwire
Jun 20184201Highwire
Jun 2018045pmc
Jul 20182600Highwire
Aug 20181900Highwire
Aug 2018577pmc
Sep 20181900Highwire
Oct 20182600Highwire
Nov 20182813Highwire
Dec 20184700Highwire
Jan 20192400Highwire
Feb 20191800Highwire
Mar 20191400Highwire
Apr 2019800Highwire
May 20191900Highwire
Jun 20191100Highwire
Jul 20192000Highwire
Aug 20191231Highwire
Sep 2019923Highwire
Oct 20191800Highwire
Nov 20194700Highwire
Dec 20191911Highwire
Jan 20202500Highwire
Feb 2020900Highwire
Mar 20203502Highwire
Apr 2020400Highwire
May 2020900Highwire
Jun 20201301Highwire
Jul 20201300Highwire
Aug 20201600Highwire
Sep 20201700Highwire
Oct 20201800Highwire
Nov 20202710Highwire
Dec 20202011Highwire
Jan 20211000Highwire
Feb 20211800Highwire
Mar 20212320Highwire
Apr 20211800Highwire
May 20212600Highwire
Jun 20211700Highwire
Jul 20212500Highwire
Aug 20211501Highwire
Sep 20211400Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me